<DOC>
	<DOC>NCT00325130</DOC>
	<brief_summary>Data from this study are expected to demonstrate that V501 (Human Papillomavirus (HPV) [Types 6, 11, 16, 18] Recombinant Vaccine) , when administered concomitantly with a combined diphtheria, tetanus, pertussis (Tdap) vaccine and a meningococcal conjugate vaccine in adolescents remains immunogenic and well-tolerated and it does not impair the immunogenicity of the concomitant vaccines.</brief_summary>
	<brief_title>Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)</brief_title>
	<detailed_description />
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Neoplasms, Glandular and Epithelial</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Must be healthy boys or girls, 1117 years of age Must be a virgin with no intention of becoming sexually active during the study period Must have been properly vaccinated against diphtheria, tetanus and pertussis Must not have received a vaccine against diphtheria, tetanus and pertussis in the past 5 years Must not have received any prior human papillomavirus (HPV) vaccine or meningococcal vaccine</criteria>
	<gender>All</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>